CK2 was one of the first protein kinases identified to be altered in an AD brain [35, 36], but its role in AD has been somewhat controversial due to discrepancies in the ability to detect consistent alterations in different affected tissues. The gene discussed is WEE1; the disease is Alzheimer disease.